US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 1.700
  • -3.190-65.24%
Close Nov 27 16:00 ET
  • 1.680
  • -0.020-1.18%
Post 20:02 ET
40.21MMarket Cap-288P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Aug 14, 20242024/Q30.000 / 0.000--
May 16, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Aug 14, 20242024/Q30.000 / 0.000--
May 16, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Outlook Therapeutics Earnings Reports

  • Outlook Therapeutics | 10-Q: Q3 2024 Earnings Report

    Aug 14 16:21 ET

  • Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

    Aug 14 07:49 ET

  • Outlook Therapeutics | 10-Q: Q2 2024 Earnings Report

    May 15 17:22 ET

  • Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

    May 15 17:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data